Cannabis: Exploring the evidence and clinical implications with Dr. Kevin Hill

“I think most physicians should be aware that there is some evidence.”

Cannabis continues to be a topic of interest to clinicians and in this episode of Quick Takes Dr. David Gratzer sits down with Dr. Kevin Hill of Beth Israel Deaconess Medical Center and Harvard Medical School to discuss where we are at with using cannabinoids in treatment.

In this discussion we learn:
• there is a link between patients with AUD and OUD and long-term cannabis use
• some “droplets” of data that cannabis is effective as an adjunct pharmacotherapy for schizophrenia do exist
• the science isn’t keeping up with patients’ desire to use it therapeutically
• and, for the most part, the doses of CBD and THC that people might need for the disorders that they are trying to receive a relief from are much higher than what most people are taking.

Follow us on Twitter

THANKS FOR LISTENING!

Quick Takes is a production of the Center for Addiction and Mental Health. You can find links to the relevant content mentioned in the show and accessible transcripts of all the episodes we produce online at CAMH.ca.

Follow CAMH Education on X (formerly known as Twitter) @camhEdu

Follow and subscribe to Reading of the Week where, every week, Dr. David Gratzer reviews research papers from the world of psychiatry.